CA2513148A1 - Kinases et recepteurs gpcr impliques dans l'apoptose - Google Patents

Kinases et recepteurs gpcr impliques dans l'apoptose Download PDF

Info

Publication number
CA2513148A1
CA2513148A1 CA002513148A CA2513148A CA2513148A1 CA 2513148 A1 CA2513148 A1 CA 2513148A1 CA 002513148 A CA002513148 A CA 002513148A CA 2513148 A CA2513148 A CA 2513148A CA 2513148 A1 CA2513148 A1 CA 2513148A1
Authority
CA
Canada
Prior art keywords
apoptosis
sequence
protein
cell
polypeptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002513148A
Other languages
English (en)
Inventor
Liam Seery
Ian Hayes
Finbarr Murphy
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
EiRx Therapeutics Ltd
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB0301566.6A external-priority patent/GB0301566D0/en
Application filed by Individual filed Critical Individual
Publication of CA2513148A1 publication Critical patent/CA2513148A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5091—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing the pathological state of an organism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5011—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing antineoplastic activity
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5082—Supracellular entities, e.g. tissue, organisms
    • G01N33/5088—Supracellular entities, e.g. tissue, organisms of vertebrates
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2510/00—Detection of programmed cell death, i.e. apoptosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Cell Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Toxicology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
CA002513148A 2003-01-23 2004-01-23 Kinases et recepteurs gpcr impliques dans l'apoptose Abandoned CA2513148A1 (fr)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB0301566.6 2003-01-23
GBGB0301566.6A GB0301566D0 (en) 2003-01-23 2003-01-23 Kinasaes and GPCRs involved in apoptosis
US45753303P 2003-03-25 2003-03-25
US60/457,533 2003-03-25
PCT/GB2004/000271 WO2004065959A2 (fr) 2003-01-23 2004-01-23 Kinases et recepteurs gpcr impliques dans l'apoptose

Publications (1)

Publication Number Publication Date
CA2513148A1 true CA2513148A1 (fr) 2004-08-05

Family

ID=32773972

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002513148A Abandoned CA2513148A1 (fr) 2003-01-23 2004-01-23 Kinases et recepteurs gpcr impliques dans l'apoptose

Country Status (5)

Country Link
EP (1) EP1588163A2 (fr)
JP (1) JP2006518590A (fr)
AU (1) AU2004205785A1 (fr)
CA (1) CA2513148A1 (fr)
WO (1) WO2004065959A2 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0328928D0 (en) * 2003-12-12 2004-01-14 Cancer Rec Tech Ltd Materials and methods relating to cell cycle control
CA2555675A1 (fr) * 2004-02-10 2005-08-25 Trustees Of Dartmouth College Compositions de nicotinamide riboside kinase et procedes d'utilisation
ATE534736T1 (de) * 2004-06-14 2011-12-15 Galapagos Nv Identifizierungsverfahren und verbindungen für die behandlung degenerativer und entzündlicher erkrankungen
US20060211004A1 (en) * 2005-02-15 2006-09-21 Ilsley Diane D Methods and compositions for determining non-specific cytotoxicity of a transfection agent
JP4854334B2 (ja) * 2006-03-06 2012-01-18 三洋電機株式会社 核酸増幅生成物のリアルタイム検出装置

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6500938B1 (en) * 1998-01-30 2002-12-31 Incyte Genomics, Inc. Composition for the detection of signaling pathway gene expression
GB9807848D0 (en) * 1998-04-09 1998-06-10 Medical Res Council Assay method and means
WO2001046468A2 (fr) * 1999-12-21 2001-06-28 Eirx Therapeutics Ltd Technique de recherche
AU2001269326A1 (en) * 2000-07-07 2002-01-21 Eirx Therapeutics Limited Screening method
JP2002139493A (ja) * 2000-11-01 2002-05-17 Sumitomo Pharmaceut Co Ltd 新規なハイスループット・スクリーニング方法
GB0206861D0 (en) * 2002-03-22 2002-05-01 Glaxo Group Ltd Medicaments

Also Published As

Publication number Publication date
JP2006518590A (ja) 2006-08-17
AU2004205785A1 (en) 2004-08-05
EP1588163A2 (fr) 2005-10-26
WO2004065959A2 (fr) 2004-08-05
WO2004065959A3 (fr) 2004-11-25
AU2004205785A8 (en) 2004-08-05

Similar Documents

Publication Publication Date Title
Gwack et al. Biochemical and functional characterization of Orai proteins
US9932378B2 (en) Regulators of NFAT
Augustin et al. Identification and characterization of human glucose transporter-like protein-9 (GLUT9): alternative splicing alters trafficking
Gongora et al. Molecular cloning of a new interferon-induced PML nuclear body-associated protein
Iwai et al. Molecular cloning of mouse type 2 and type 3 inositol 1, 4, 5-trisphosphate receptors and identification of a novel type 2 receptor splice variant
Charest et al. Association of a novel PDZ domain-containing peripheral Golgi protein with the Q-SNARE (Q-solubleN-ethylmaleimide-sensitive fusion protein (NSF) attachment protein receptor) protein syntaxin 6
Basu et al. Localization of the Drosophila checkpoint control protein Bub3 to the kinetochore requires Bub1 but not Zw10 or Rod
Pereira et al. IMPACT, a protein preferentially expressed in the mouse brain, binds GCN1 and inhibits GCN2 activation
Kim et al. Molecular characterization of mammalian homologues of class C Vps proteins that interact with syntaxin-7
Hruska-Hageman et al. PSD-95 and Lin-7b interact with acid-sensing ion channel-3 and have opposite effects on H+-gated current
Matsuo et al. Identification of a novel Na+-independent acidic amino acid transporter with structural similarity to the member of a heterodimeric amino acid transporter family associated with unknown heavy chains
Hannan et al. Affinity purification of mammalian RNA polymerase I: identification of an associated kinase
Thévenot et al. p21-Activated kinase 3 (PAK3) protein regulates synaptic transmission through its interaction with the Nck2/Grb4 protein adaptor
Jin et al. Ring finger protein 34 (RNF34) interacts with and promotes γ-aminobutyric acid type-A receptor degradation via ubiquitination of the γ2 subunit
US20060121498A1 (en) Enzymes involved in apoptosis
US20080108098A1 (en) Novel germinal kinase proteins, compositions and methods of use
Joseph et al. A conformational change within the WAVE2 complex regulates its degradation following cellular activation
Xu et al. Evidence for gelsolin as a corneal crystallin in zebrafish
Benziane et al. NKCC2 surface expression in mammalian cells: down-regulation by novel interaction with aldolase B
US20040219616A1 (en) Apoptosis-related kinase/GPCRs
US20050019746A1 (en) Apoptosis-related kinase/GPCRs
CA2513148A1 (fr) Kinases et recepteurs gpcr impliques dans l'apoptose
US20030104500A1 (en) Enzymatic assays for screening anti-cancer agents
US6660511B1 (en) Methods of screening for modulation of cell cycle
WO2003074007A2 (fr) Modulateurs d'activation des leucocytes, compositions, et methodes d'utilisation

Legal Events

Date Code Title Description
FZDE Dead